C07K 14/28
From vibrionaceae
Official title: from Vibrionaceae (F)
C07K14/28 (From vibrionaceae) appears on 275 US grants and 322 published applications in this corpus.
Search patents in C07K- Granted patents
- 275
- Published applications
- 322
- Assignees
- 186
- Inventors
- 581
- Latest grant
- 21 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1981 | 1 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 1 | 0 |
| 1987 | 2 | 0 |
| 1988 | 1 | 0 |
| 1989 | 2 | 0 |
| 1990 | 2 | 0 |
| 1991 | 1 | 0 |
| 1992 | 3 | 0 |
| 1993 | 4 | 0 |
| 1994 | 3 | 0 |
| 1995 | 6 | 0 |
| 1996 | 1 | 0 |
| 1997 | 5 | 0 |
| 1998 | 11 | 0 |
| 1999 | 23 | 0 |
| 2000 | 11 | 0 |
| 2001 | 6 | 1 |
| 2002 | 2 | 7 |
| 2003 | 4 | 11 |
| 2004 | 4 | 12 |
| 2005 | 2 | 15 |
| 2006 | 4 | 15 |
| 2007 | 14 | 12 |
| 2008 | 9 | 34 |
| 2009 | 17 | 8 |
| 2010 | 19 | 14 |
| 2011 | 7 | 8 |
| 2012 | 7 | 8 |
| 2013 | 8 | 15 |
| 2014 | 8 | 8 |
| 2015 | 6 | 13 |
| 2016 | 1 | 14 |
| 2017 | 6 | 2 |
| 2018 | 7 | 15 |
| 2019 | 8 | 13 |
| 2020 | 10 | 10 |
| 2021 | 11 | 19 |
| 2022 | 15 | 11 |
| 2023 | 4 | 16 |
| 2024 | 8 | 18 |
| 2025 | 6 | 10 |
| 2026 | 5 | 13 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Deimmunized flagellin and vaccine composition comprising same21 Jul 2026US 12,685,770 B2FlagImmune
- Genetically modified probiotics for oral delivery of renin-angiotensin related therapeutic proteins and peptides9 Jun 2026US 12,649,770 B2University of Florida Research Foundation, Inc.
- Fusion constructs to express biopharmaceutical polypeptides in cyanobacteria28 Apr 2026US 12,612,638 B2The Regents of the University of California
- Recombinant proteins and their therapeutic uses10 Mar 2026US 12,570,708 B2
- Vibrio cholerae protein for use against cancer27 Jan 2026US 12,533,393 B2Linnane Pharma AB
- Genetically modified probiotics for oral delivery of renin-angiotensin related therapeutic proteins and peptides1 Oct 2026US 2026/0297153 A1
- A broadly protective prophylactic vaccine against pseudomonas aeruginosa24 Sep 2026US 2026/0284172 A1University of Kansas
- Fusion protein, corresponding nucleic acid, in-vitro synthesis system, and preparation method10 Sep 2026US 2026/0265314 A1Kangma-Healthcode (Shanghai) Biotech Co., Ltd.
- Modified carrier proteins for o-linked glycosylation6 Aug 2026US 2026/0224696 A1Glaxosmithkline Biologicals SA
- Antibiotic-free Miniplasmid, and Preparation Method Therefor and Use Thereof6 Aug 2026US 2026/0226498 A1Maxirna (Shanghai) Pharmaceutical Co. Ltd.
Most cited
By later US patents
- DNA-based vaccination of fish162US 5,780,448 AOttawa Civic Hospital Loeb Research · 1998
- Production of polyunsaturated fatty acids by expression of polyketide-like synthesis genes in plants135US 6,140,486 ACalgene, Inc. · 2000
- Hybrid molecules having translocation region and cell-binding region126US 5,668,255 ASeragen, Inc. · 1997
- Schizochytrium PKS genes123US 6,566,583 B12003
- PUFA polyketide synthase systems and uses thereof99US 7,211,418 B2Martek Biosciences Corporation · 2007